ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic
Condition(s):History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 InfectionLast Updated:April 9, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 InfectionLast Updated:April 9, 2021Terminated
Condition(s):Obese; Type 2 Diabetes; Diabetic Nephropathy; Glucose Metabolism; Angiotensin II Type 1 Receptor BlockersLast Updated:November 21, 2007Completed
Condition(s):Renal Insufficiency, Chronic; ProteinuriaLast Updated:February 22, 2019Unknown status
Condition(s):Diabetes; Hypertensive DiseaseLast Updated:September 5, 2016Unknown status
Condition(s):Biopsy-proven IgA NephropathyLast Updated:February 8, 2019Unknown status
Condition(s):Chronic Kidney DiseaseLast Updated:September 15, 2016Unknown status
Condition(s):Hypertension; Chronic Kidney Disease; ProteinuriaLast Updated:March 16, 2016Completed
Condition(s):Safety Issues; Chronic Kidney DiseasesLast Updated:April 14, 2021Completed
Condition(s):COVID 19Last Updated:April 24, 2020Unknown status
Condition(s):Diabetes Mellitus, Type 2; Diabetic Kidney DiseaseLast Updated:October 8, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.